Conagra Brands (NYSE:CAG) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.52 by 9.62 percent. This is a 14 percent increase over earnings of $0.50 per share from the same period last year. The company reported quarterly sales of $2.90 billion which beat the analyst consensus estimate of $2.85 billion by 1.89 percent. This is a 9.46 percent increase over sales of $2.65 billion the same period last year.
Regeneron Pharmaceuticals: Q2 Earnings Insights
Shares of Regeneron Pharmaceuticals (NASDAQ:REGN) moved higher by 0.0% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were up 260.34% year over year to $25.80, which beat the estimate of $17.69.